Construction and validation of a prognostic model based on mitochondria-associated endoplasmic reticulum membranes gene signature in LUAD patients
PLOS One · 2025
DOI: 10.1371/journal.pone.0330722 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift PLOS One, 2025. Verfasst von Qichen Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: The First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Endoplasmic Reticulum, Lung Neoplasms, Mitochondria. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Gansu Science and Technology Project, The First Hospital of Lanzhou University Hospital Fund, The Longyuan Youth Innovation and Entrepreneurship Talent Team Project from the Organization Department of CPC Gansu Provincial Party Committee.
Abstract (Originalsprache)
Background
Mitochondrial-associated endoplasmic reticulum membranes (MAM) are implicated in various malignancies, but their prognostic value in lung adenocarcinoma (LUAD) remains underexplored.
Methods
The Cancer Genome Atlas (TCGA) and GeneCards databases provided LUAD patient data and MAM-related genes. Differentially expressed genes (DEGs) were identified using the “Limma” package. Enrichment analyses included Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), Gene Set Variation Analysis (GSVA), and Gene Set Enrichment Analysis (GSEA). A prognostic risk model based on MAM genes was constructed using univariate, least absolute shrinkage and selection operator (LASSO), and multivariate Cox regression analyses, validated by Receiver Operating Characteristic (ROC) curve analysis. PPI explored intergene relationships, while immune infiltration analysis investigated underlying mechanisms. The Human Protein Atlas (HPA) validated key gene protein expression, and drug sensitivity was analyzed using the Gene Set Cancer Analysis (GSCA) database. Finally, we also performed immunohistochemistry (IHC) staining in the tissue samples.
Results
A prognostic risk model with 3 MAM genes (ERO1A, SHC1, CCT6A) was established from 194 DEGs-MAM. Kaplan-Meier analysis showed significantly longer OS in the low-risk group. Enrichment analyses indicated MAM genes were primarily involved in immune-related pathways. TIMER analysis linked the 3 MAM genes with immune cell infiltration (CD8 + T cells, CD4 + T cells, B cells, macrophages). Expression and prognostic analyses revealed high expression of these mRNAs and proteins in LUAD tissues.
Conclusions
This study constructed a prognostic risk model for LUAD based on 3 MAM genes, revealing a potential link between MAM genes and LUAD, offering new insights into clinical treatment and prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu, China.
- Department of Respiratory Oncology, Gansu Provincial Cancer Hospital, Lanzhou, Gansu, China.
- Department of Pathology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.
- Department of Oncology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.
- Department of Oncology, The Second Hospital of Lanzhou University, Lanzhou, Gansu, China.
- Gansu Province Clinical Research Center for Thoracic Tumor, Lanzhou, Gansu, China.
ORCID-Profile: Hui Qiao
Förderung
- The Gansu Science and Technology Project
- The First Hospital of Lanzhou University Hospital Fund
- The Longyuan Youth Innovation and Entrepreneurship Talent Team Project from the Organization Department of CPC Gansu Provincial Party Committee
- The Lanzhou Science and Technology Bureau 2023 Science and Technology Plan Project
- The Construction Project of Clinical Medical Research Center from Gansu Provincial Department of Science and Technology
Zitieren
APA
Zhang, Q., Fu, C., Liu, S., Leng, Y., Duan, L., Wang, N., Zhang, L., & Qiao, H. (2025). Construction and validation of a prognostic model based on mitochondria-associated endoplasmic reticulum membranes gene signature in LUAD patients. PLOS One. https://doi.org/10.1371/journal.pone.0330722
Vancouver
Zhang Q, Fu C, Liu S, Leng Y, Duan L, Wang N, et al. Construction and validation of a prognostic model based on mitochondria-associated endoplasmic reticulum membranes gene signature in LUAD patients. PLOS One. 2025. doi:10.1371/journal.pone.0330722
BibTeX
@article{Zhang2025,
author = {Zhang, Qichen and Fu, Caihong and Liu, Shasha and Leng, Yue and Duan, Ling and Wang, Na and Zhang, Longxia and Qiao, Hui},
title = {Construction and validation of a prognostic model based on mitochondria-associated endoplasmic reticulum membranes gene signature in LUAD patients},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0330722}
}
EUVIMED